Cytokinetics | CYTK - Ordinary Share Capital


Cytokinetics reported $122.12M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 168.71M 104K Sep/2025
Amgen USD 538M 300K Sep/2025
Bayer EUR 982.42M 0 Sep/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cytokinetics USD 122.12M 2.52M Sep/2025
Eisai JPY 282.12M 0 Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Exelixis USD 268.1M 2.03M Sep/2025
Geron USD 638.02M 637.38M Sep/2025
Halozyme Therapeutics USD 117.52M 98K Sep/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Ligand Pharmaceuticals USD 20K 0 Mar/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025